There can be distinct advantages of moving to contract manufacturing if your product is already in production.

Here are some factors to consider when deciding whether to engage a CDMO when your product is in production:

Capacity constraints: If your current production capacity is insufficient to meet growing demand for your life science or IVD manufacturing, or you need to scale up quickly, engaging a CDMO can provide the additional capacity required to support your expansion.

Cost optimization: A CDMO can offer cost efficiencies by leveraging their expertise, specialized equipment, and established supply chains. This can result in reduced production costs and increased profitability.

Focus on core competencies: Outsourcing production to a CDMO allows your company to focus on its core competencies, such as research and development, sales and marketing, or expanding your product portfolio.

Regulatory compliance: A CDMO with experience in regulatory compliance can help ensure that your product continues to meet the necessary standards and requirements, potentially reducing the risk of non-compliance issues.

However, there are challenges to consider when transitioning to a CDMO during the production phase:

Tech transfer complexities: Transferring production to a CDMO at this stage can be more complex and time-consuming, as they will need to adapt to your processes, equipment, and requirements. This can result in delays and increased costs.

Intellectual property protection: Ensuring the protection of your intellectual property during the transition to a CDMO is critical. It’s essential to establish a clear agreement outlining the terms of the partnership and the measures in place to protect your intellectual property.

Potential production disruption: Transferring production to a CDMO can help minimize these disruptions.

In conclusion, while it may be more challenging to engage a biotech contract manufacturer during the production phase, it is not too late to do so. Carefully weighing the potential benefits and challenges can help you determine if partnering with a CDMO like Argonaut is the right decision for your product at this stage. A successful transition can provide additional capacity, cost optimization, and allow your company to focus on its core competencies.